Medtronic Settles On Country-Of-Origin Allegations
This article was originally published in The Gray Sheet
Executive Summary
The suit follows similar charges against Smith & Nephew. In both instances, the companies are alleged to have sold devices to the federal government that were made in China or other countries that do not have trade agreements with the U.S. but repackaged and relabeled as made in the U.S.
You may also be interested in...
Ambu Settles US Defense Department False-Claims Allegations
Danish device-maker Ambu has agreed to pay $3.3m to resolve allegations of False Claims Act violations. The company is said to have made medical product in Malaysia and China for sale to the Departments of Defense and Veterans Affairs, which is forbidden under the Trade Agreements Act.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.